// App-Quantinova.ai

POS0408 (2021) : INVESTIGATING THE ANTI-INFLAMMATORY POTENTIAL OF A NOVEL MK2 INHIBITOR IN A VITRO MODEL OF ENTHESITIS

Researchers

Presenter

  • C. Bridgewood

Principal Investigators

  • C. Wong

  • R. Gaur

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Bristol Myers Squibb, Immunology, Cardiovascular and Fibrosis Thematic Research Center, Cambridge, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Interleukin 13

  • Interleukin 17A

  • Interleukin-2

  • Interleukin 18

  • Interleukin-22

  • Interleukin-23

  • Interleukin 4

  • Interleukin-8

  • Interleukin-9

  • Interleukin 5

  • Interleukin 6

  • Interferon-gamma

  • Interleukin 1 beta

  • Interleukin 10

  • Tumor necrosis factor

Drug/Treatment

  • Interferon Gamma

  • Interleukin-10

  • IL-4

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved